BPC-157 (Body Protection Compound-157) is a 15-amino-acid gastric pentadecapeptide that promotes angiogenesis through VEGF upregulation and protects tissue through nitric oxide system modulation
Results BPC-157 accelerates wound closure in alkali-burned rats During the study, no abnormalities were observed in the general condition and behavior of rats in all treatment cohorts, including asitia, nausea, diarrhea, cough, or weight loss, and no symptoms of allergic response such as hydroposia or localized rash occurred in animals receiving bFGF or BPC-157
In reality, in particular along with its safety profile, LD-1 is not achieved, and there are no reported adverse effects in clinical trials
Complementary mechanisms: TRT provides the hormonal foundation (anabolism, energy, libido), while BPC-157 supports the structural foundation (tissue integrity, inflammation control, healing)